Jonas Salk: The Man Who Beat Polio - Interesting Engineering

Jonas Salk: The Man Who Beat Polio - Interesting Engineering

Jonas Salk: The Man Who Beat Polio - Interesting Engineering

Posted: 23 Jun 2019 12:41 AM PDT

[unable to retrieve full-text content]Jonas Salk: The Man Who Beat Polio  Interesting Engineering

Thanks the Jonas Salk, millions, if not billions of children today go safely go about their lives without the fear of being struck down by Polio.

Polio (Poliomyelitis) Vaccines Market –Segmentation and Industrial Overview Forecasts to 2025 - A Technology Market

Posted: 20 Jun 2019 03:43 AM PDT

Global Polio (Poliomyelitis) Vaccines Market Report 2019 offers a comprehensive analysis on Polio (Poliomyelitis) Vaccines industry, delivering detailed market data and penetrating insights. The report provides analysis which is beneficial for industry insider, potential entrant and investor.The Polio (Poliomyelitis) Vaccines report will the thorough study of the key business players to grasp their business methods, annual revenue, company profile and their contribution to the world Polio (Poliomyelitis) Vaccines market share.The report covers a huge area of information including an industry overview, comprehensive analysis, definitions and classifications, applications, and expert opinions.

The research report on Polio (Poliomyelitis) Vaccines Market keenly analyzes significant features of the industry. The analysis servers market size, latest trends, drivers, threats, opportunities, as well as key market segments. It is based on past data and present market needs. Also, involve distinct business approaches accepted by the decision makers. That intensifies growth and make a remarkable stand in the industry.

Request For Sample: https://www.garnerinsights.com/Global-Polio-Poliomyelitis-Vaccines-Market-Report-History-and-Forecast-2014-2025-Breakdown-Data-by-Manufacturers-Key-Regions-Types-and-Application#request-sample

Key players in the Global Polio (Poliomyelitis) Vaccines market:

Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals,

In the same way, the report covers Type as follows:

Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV),

In terms of application, the segment is split into the following:

Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others,

The research report on Polio (Poliomyelitis) Vaccines Market acute analyzes significant features of the industry. The analysis servers market size, latest trends, drivers, threats, opportunities, as well as key market segments. It is based on past data and present market needs. Also, involve distinct business approaches accepted by the decision makers. That intensifies growth and make a remarkable stand in the industry.The Polio (Poliomyelitis) Vaccines market will grow with a significant CAGR between 2019 to 2025. The report segregates the complete market on the basis of key players, geographical areas, and segments.

 Check Discount: https://www.garnerinsights.com/Global-Polio-Poliomyelitis-Vaccines-Market-Report-History-and-Forecast-2014-2025-Breakdown-Data-by-Manufacturers-Key-Regions-Types-and-Application#discount

The Asia Pacific Polio (Poliomyelitis) Vaccines market is projected to grow at the highest CAGR from 2019 to 2025. The growth of the Asia Pacific region can be attributed to the increased air passenger traffic in the region. Growing disposable income of the middle-class population of emerging economies such as China and India of the Asia Pacific region is also contributing to the growth of the market in the region. China is expected to be a major market for Polio (Poliomyelitis) Vaccines in the Asia Pacific region, owing to reforms in their aviation regulations and policies, formulation of innovative airport business models, and incorporation of innovative technologies in various airport systems.

Full Report With TOC : https://www.garnerinsights.com/Global-Polio-Poliomyelitis-Vaccines-Market-Report-History-and-Forecast-2014-2025-Breakdown-Data-by-Manufacturers-Key-Regions-Types-and-Application

The study objectives are:

  • The market research report provides an integrated information on the major drivers, restraints and opportunities influencing the industry growth, during the forecast period.
  • The study further drills down to produce data volume by components, end customers and demography.
  • SWOT analysis of major brands, highlights weaknesses, strengths, opportunities and threats. The data proves effective for business owners planning on designing their marketing and branding strategies.
  • Region wise business performance discussed in the market research report would be valuable for enterprises planning to explore new areas.
  • The report not only examines the market dynamics but also takes a closer look at the growth rate and industrial chain structure.
  • Study further weigh up on the prominent market players and what they are doing different to position their product in the already crowded marketplace.
  • Assessment of upstream and downstream market also forms an important part of the report.

Last, It offers in-depth information obtained through extensive primary and secondary research methods. The information has been further assessed using various effective analytical tools. Therefore, the report provides a 360-degree view of the Polio (Poliomyelitis) Vaccines market.

If You want Details on Polio (Poliomyelitis) Vaccines market Report, Please Email: sales@garnerinsights.com"

Progress Toward Polio Eradication January 2017-March 2019 - Medscape

Posted: 11 Jun 2019 09:27 PM PDT

Authors and Disclosures

Sharon A. Greene, PhD1,2, Jamal Ahmed, MD3, S. Deblina Datta, MD2, Cara C. Burns, PhD4, Arshad Quddus, MD3, John F. Vertefeuille, PhD2 and Steven G.F. Wassilak, MD2

1Epidemic Intelligence Service, CDC; 2Global Immunization Division, Center for Global Health, CDC; 3Polio Eradication Department, World Health Organization, Geneva, Switzerland; 4Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC.

Corresponding author
Sharon A. Greene, sgreene@cdc.gov, 404-718-7186.

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Comments

Post a Comment

Popular posts from this blog

Roseola vs. measles rash: What is the difference? - Medical News Today

Image
Roseola and measles are two different diseases that present with a high fever and a rash. They are both most commonly seen in childhood, although measles can affect people of any age, and roseola in adults is very rare. While both diseases share similarities, there are distinguishing factors, such as how the symptoms present and the disease progression. Read on to find out the difference between roseola and measles rashes. Roseola, also known as roseola infantum, sixth disease, or exanthema subitum, is a viral infection that typically affects children. The human herpesvirus 6 (HHV-6) or human herpesvirus 7 (HHV-7) causes roseola. The disease is spread through tiny respiratory droplets that people either breathe in or pick up from surfaces they touch. This disease usually presents in children between the ages of 6–12 months . Children who have this disease experience a high fever, followed by a pink or red rash. Roseola is a self-limiting viral illness, meaning it will typically go awa...
Read more

poliomyelitis treatment

Image
poliomyelitis treatment Drug and Device News March 2019 - P&T Community Posted: 04 Mar 2019 10:35 AM PST NEW DRUG APPROVALS Ontruzant, a Herceptin Biosimilar The FDA has approved trastuzumabdttb (Ontruzant, Samsung Bioepis Company, Ltd.) for HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. Trastuzumabdttb, a HER2/neu receptor antagonist, is the third FDA-approved biosimilar of Herceptin (Genentech). Patients should be selected for therapy based on an FDA-approved companion diagnostic. Trastuzumab-dttb carries a boxed warning about the risks of cardiomyopathy, serious and fatal infusion reactions, embryo-fetal toxicity, and pulmonary toxicity. Ontruzant will be marketed and distributed in the U.S. by Merck. Sources: Samsung Bioepis, January 21, 2019; Ontruzant . prescribing information, January 2019; FDA, January 18, 2019 Vaxelis, a Combination Vaccine T...
Read more

Coronavirus fake news echoes century-old polio fears - Newsroom

Image
Coronavirus fake news echoes century-old polio fears - Newsroom Coronavirus fake news echoes century-old polio fears - Newsroom Posted: 05 Feb 2020 08:32 AM PST FEBRUARY 6, 2020 Updated 15 hours ago Dr Heather Battles Dr Heather Battles is a lecturer in anthropology at the University of Auckland and researches infectious diseases and epidemics. Show more Ideasroom During the past month, in the confusion and uncertainty over the precise origin of the 2019 novel coronavirus outbreak, many alternate ideas or 'conspiracy theories' have sprung up and spread widely via social media including Twitter and Facebook. I have had a sense of déjà vu as many of these claims have parallels in how people responded to another 'emerging' epidemic disease a century ago: polio. The first example that struck me is the idea (spread by US fake news website Infowars and others) that the roll-out of 5G technology is to blame, wit...
Read more